Differentiation therapy revisited
Top Cited Papers
- 1 December 2017
- journal article
- review article
- Published by Springer Science and Business Media LLC in Nature Reviews Cancer
- Vol. 18 (2), 117-127
- https://doi.org/10.1038/nrc.2017.103
Abstract
The concept of differentiation therapy emerged from the fact that hormones or cytokines may promote differentiation ex vivo, thereby irreversibly changing the phenotype of cancer cells. Its hallmark success has been the treatment of acute promyelocytic leukaemia (APL), a condition that is now highly curable by the combination of retinoic acid (RA) and arsenic. Recently, drugs that trigger differentiation in a variety of primary tumour cells have been identified, suggesting that they are clinically useful. This Opinion article analyses the basis for the clinical successes of RA or arsenic in APL by assessing the respective roles of terminal maturation and loss of self-renewal. By reviewing other successful examples of drug-induced tumour cell differentiation, novel approaches to transform differentiating drugs into more efficient therapies are proposed.This publication has 226 references indexed in Scilit:
- The Origin and Evolution of Mutations in Acute Myeloid LeukemiaCell, 2012
- Vitamin D metabolism and innate immunityMolecular and Cellular Endocrinology, 2011
- The Role of Retinoic Acid in Tolerance and ImmunityImmunity, 2011
- The self-association coiled-coil domain of PML is sufficient for the oncogenic conversion of the retinoic acid receptor (RAR) alphaLeukemia, 2011
- Toolkit for evaluating genes required for proliferation and survival using tetracycline-regulated RNAiNature Biotechnology, 2011
- CD4+ T Cells Contribute to the Remodeling of the Microenvironment Required for Sustained Tumor Regression upon Oncogene InactivationCancer Cell, 2010
- Selective inhibition of BET bromodomainsNature, 2010
- Vitamin D3-driven signals for myeloid cell differentiation—Implications for differentiation therapyLeukemia Research, 2010
- Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomasNature, 2007
- MYC inactivation uncovers pluripotent differentiation and tumour dormancy in hepatocellular cancerNature, 2004